Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06106139 |
Other study ID # |
LYSY20230510 |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
Phase 1/Phase 2
|
First received |
|
Last updated |
|
Start date |
May 12, 2024 |
Est. completion date |
June 10, 2025 |
Study information
Verified date |
March 2024 |
Source |
Fujian Medical University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The main purpose of this study is to evaluate whether dietary intervention through ketogenic
diet can prevent or improve chemotherapy related thrombocytopenia in cancer patients.
Description:
In the study, 80 patients with malignant solid tumors undergoing chemotherapy were randomly
assigned to the normal diet group, the strict ketogenic diet group, the circulating ketogenic
diet group, and the autonomous ketogenic group. During the chemotherapy period, the
corresponding dietary intervention was carried out, and the clinical data of patients before
and after treatment were collected, including blood routine, blood ketone concentration,
weight, blood sugar, blood lipids, adverse events, and changes in platelets before and after
chemotherapy, Statistical analysis of data such as the change degree of platelets and the
incidence of adverse events in each diet group before and after treatment was carried out to
evaluate the impact of ketogenic diet on clinical indicators and adverse reactions of
chemotherapy in cancer patients.